Trudeau Institute

Trudeau Institute is a nonprofit biomedical research enterprise with a mission to safeguard human health and combat 21st-century global health crises. Specializing in immunology and infectious disease research, Trudeau Institute focuses on deadly pathogens including tuberculosis, SARS-CoV-2, Zika, influenza, and tick-borne Powassan virus. With roots tracing back to 1884, Trudeau Institute has a rich legacy, initially dedicated to tuberculosis research. The cornerstone of Trudeau Institute's strategy, the Trudeau Research Network (TRN), aims to expand the reach of their labs and accelerate progress in discovering and optimizing innovative treatment options against infectious diseases. Partnering with institutions such as the Walter Reed Army Institute of Research, SUNY Upstate Medical University, Albert Einstein College of Medicine, Texas Biomedical Research Institute, global biopharmaceutical companies, and large non-profit global health organizations, Trudeau Institute has established itself as a collaborative leader in the field. Beyond research, Trudeau Institute also prioritizes education initiatives, offering programs such as the Clarkson Trudeau Biomedical Scholars project and the Summer Undergraduate Research Program (SURP) to nurture future talent in the field of biomedical research. In response to the COVID-19 pandemic, Trudeau Institute played a crucial role in the community by manufacturing scarce COVID testing fluid for the Adirondack Health Medical Center and establishing a regional COVID Testing Lab for the underserved North Country, with the capacity of 1,000 tests daily. This proactive response displayed the institute's commitment to real-time community pandemic support and readiness for the next outbreak. Trudeau Institute's dedication to impactful research, education, and proactive pandemic response makes it a noteworthy player in the biopharma and biotechnology industries.